MBBS - Dr. NTR University of Health Sciences Andhra Pradesh - 2001
MD - Radiotherapy - Nizam Institute of Medical Sciences, Hyderabad - 2006
DNB - Radiotherapy - National Board Of Examination - 2011
Experiences
Registrar Yashoda Hospital - 2007 - 2008
Consultant Radiation Oncologist Yashoda Hospitals - 2008 - Currently Working
Registrations
46981 Andhra Pradesh Medical Council 2002
Awards and Recognitions
Research and Articles :
Principal investigator in Trial no 1200.161 - Trial title - A randomized- open-label- phase III study to evaluate the efficacy and safety of oral afatinib versus intravenous methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who have progressed after platinum-based therapy
Principal investigator trial numbers:1200:131 Trial title:LUX-Head and Neck 2:randomised- double blind- placebo-controlled- phase III study to evaluate the efficacy and safety of afatinib as adjuvant therapy after chemo-radiotherapy in primary unresected patients with stage III- IVa- or IVb loco-regionally advanced head and neck squamous cell carcinoma
Title: P276-00/64/11 ?A Multicenter- Phase II/III study to assess radiation induced mucositis in subjects with locally advanced squamous cell carcinoma of the head and neck- administered cisplatin and radiation with or without P276-00
Title NETU08-18: A phase III multicenter- randomized- double-blind- double-dummy-a ctive-controlled- parallel group study of the efficacy and safety of oral netupitant administered in combination with palonosetron and dexamethasone compared to oral palonosetron and dexamethasone for the prevention of nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy
Title:PALO10-01:Single dose- multicenter- randomized- double-blind- double-dummy-parallel group study to assess the efficacy and safety of oral palonosetron 0.50 mg compared to I.V palonosetron 0.25mg administered with dexamthasone for the prevention of chemotherapy- induced nausea and vomiting in cancer patients receiving highly emetogenic cisplatin - based chemotherapy
Memberships
Member - Association of Radiation Oncologist of India